Apretude | Description | MIMS Thailand

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing Local Product Insert

Full Prescribing Info

Description

Film-coated Tablet: A white, film-coated oval tablet, debossed with "SV CTV" on one face.
Each film-coated tablet contains 30 mg of cabotegravir (as cabotegravir sodium).
Suspension for Injection: White to light pink, prolonged-release suspension for injection.
Each 3 mL vial contains 600 mg cabotegravir (as cabotegravir free acid).
Excipients/Inactive Ingredients: Film-coated tablets: Tablet core: Lactose Monohydrate, Microcystalline Cellulose, Hypromellose (E464), Sodium Starch Glycolate (Type A), Magnesium Stearate.
Tablet coating: Hypromellose (E464), Titanium Dioxide (E171), Macrogol 400 (E1521).
Suspension for Injection: Mannitol (E421), Polysorbate 20 (E432), Macrogol (E1521), Water for injections.

Apretude Description

cabotegravir

Manufacturer:

GlaxoSmithKline

Distributor:

Zuellig Pharma

Marketer:

GlaxoSmithKline